We believe that aquaculture represents the sustainable future of food and is the key to feeding the world in 2050 and beyond. By reducing disease mortality and increasing yields, our products will improve farm economics and help to secure the viability of the aquaculture industry. How?
VakSea has developed an innovative system that uses insect larvae to affordably produce specialty, immune-boosting proteins that can be delivered orally and have been shown to reduce disease-related losses in both fish and shrimp. VakSea is creating a range of protein-based products to reduce mortality caused by diseases in aquaculture and to increase yields.
Our products are:
VERSATILE: VakSea's insect larvae system can be used to produce high-quality immunoprotective proteins for the vast majority of viruses that impact fish and shrimp.
AFFORDABLE: VakSea can affordably and reliably produce specialty proteins and protein-based products that are traditionally difficult or not cost-efficient to manufacture.
SIMPLE TO PRODUCE: VakSea can produce bioactive proteins that offer strong immunoprotection inside insect larvae, eschewing the complex, multi-step biochemical production and purification systems that are typically required.
EASY TO DELIVER: VakSea incorporates its immune-boosting proteins into traditional feed, enabling farmers to simply feed them to fish without worrying about proper dosing.
VakSea has developed an innovative system that uses insect larvae to affordably produce specialty, immune-boosting proteins that can be delivered orally and have been shown to reduce disease-related losses in both fish and shrimp. VakSea is creating a range of protein-based products to reduce mortality caused by diseases in aquaculture and to increase yields.
Our products are:
VERSATILE: VakSea's insect larvae system can be used to produce high-quality immunoprotective proteins for the vast majority of viruses that impact fish and shrimp.
AFFORDABLE: VakSea can affordably and reliably produce specialty proteins and protein-based products that are traditionally difficult or not cost-efficient to manufacture.
SIMPLE TO PRODUCE: VakSea can produce bioactive proteins that offer strong immunoprotection inside insect larvae, eschewing the complex, multi-step biochemical production and purification systems that are typically required.
EASY TO DELIVER: VakSea incorporates its immune-boosting proteins into traditional feed, enabling farmers to simply feed them to fish without worrying about proper dosing.
Location: United States, Maryland, Baltimore
Employees: 11-50
Founded date: 2017
Investors 3
Mentions in press and media 6
| Date | Title | Description |
| 02.01.2019 | Biotrophics picks up $25K at farm and fish accelerator’s demo day | Before 2018 was through, five Baltimore agtech and aquatech startups closed out the first cohort of a new Maryland program designed to help founders build businesses and make industry connections. At the Dec. 20 demo day held inside bwtech@... |
| 20.11.2018 | VentureWell brings cleantech startups to IMET for its first Baltimore investment readiness program | In raising money, it’s key to be able to communicate what a company does and how it can provide value. Behind the scenes, there’s also a lot of practical knowledge that goes into the process. From term sheets to valuation, there are lots of... |
| 05.11.2018 | F3 Tech Accelerator supports startups working on the future of farming and fishing | An accelerator that launched this fall is seeking to help Baltimore startups working in agriculture and aquaculture, and connect with the farmers, fishers and others who can benefit from they new approaches they’re pursuing. F3 Tech Acceler... |
| 21.09.2018 | Remedy Plan Therapeutics wins Bio+Tech Conference pitch competition | The Maryland Tech Council brought the Bio+Tech Conference to Baltimore on Thursday. For the first time, the event closed out with a pitch competition featuring startups from around the state. Remedy Plan Therapeutics was named the winner, a... |
| 15.12.2017 | Ag Industry Brief: New Fund for Coops in Developing Countries, Target Buys Shipt, Soylent CEO is Out, more | Clarmondial Wins Grant from Convergence to Launch Food Securities Fund Clarmondial, a Swiss investment advisory company, won a Design Funding grant from Convergence, to build and launch an investment fund for private credit in agriculture. ... |
| 28.09.2016 | 31 startups that Baltimore research institutions should be very proud of | Universities are the secret weapon of national startup hubs like Silicon Valley and Boston. And over the last few years Baltimore has done its best to follow suit. Consider spaces like Johns Hopkins’ FastForward incubator, the University of... |